Skip to content

Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation

Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on β-endorphin

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03172234
Acronym
15/5/2017
Enrollment
90
Registered
2017-06-01
Start date
2017-06-15
Completion date
2018-05-15
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Laryngoscopy and Tracheal Intubation

Keywords

β-endorphins,laryngoscopy and tracheal intubation

Brief summary

To evaluate the effect of oral amantadine versus gabapentin premedication on the hemodynamic response to laryngoscopy and tracheal intubation and their effect on β-endorphins.

Detailed description

Direct laryngoscopy and passage of endotracheal tube through the larynx is a noxious stimulus, which can provoke untoward response in the cardiovascular, respiratory and other physiological systems. Gabapentin, is 1-aminomethyl cyclohexane acetic acid.Gabapentin is structurally related to the neurotransmitter gamma-aminobutyric acid (GABA). Gabapentin act in central nervous system CNS), it acts by decreasing the synthesis of neurotransmitter glutamate and by binding to the alpha 2 delta subunits of voltage dependent calcium channels. Amantadine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and compared to ketamine, it is well tolerated with fewer side effects (mainly dizziness, sedation, and dry mouth). Amantadine's formulation permits the oral route for drug delivery, as well as the IV route. The side-effects profile of amantadine via all routes seems not to be harmful in appropriate dosages.. Amantadine has been clinically used as an antiviral drug, for dementia, and in the treatment of Parkinson's disease and spasticity. It is a non-competitive NMDA receptor antagonist, and compared to ketamine, it is well tolerated with fewer side effects (mainly dizziness, sedation, and dry mouth). Amantadine's formulation permits the oral route for drug delivery, as well as the IV route. The side-effects profile of amantadine via all routes seems not to be harmful in appropriate dosages. In the central nervous system, beta-endorphins bind mu-opioid receptors and exert their primary action at presynaptic nerve terminals. However, instead of inhibiting substance P, they exert their analgesic effect by inhibiting the release of GABA, an inhibitory neurotransmitter, resulting in excess production of dopamine. The investigators designed this study to prove the efficacy of oral amantadine versus gabapentin premedication on the hemodynamic response to laryngoscopy and tracheal intubation and their effect on β-endorphins.

Interventions

In amantadine group:the patients will receive100 mg oral amantadine sulfate 90 minute prior to the surgery

In gabapentin group: the patients will receive oral 800 mg gabapentin 90 minute prior to the surgery

DRUGPlacebo Oral Tablet

in control group : the patients will receive Placebo Oral Tablet 90 minute prior to the surgery

Sponsors

Ghada Mohammed AboelFadl
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* ASA I&II scheduled for elective spine surgery

Exclusion criteria

* Patient refusal * Patients with ASA score III (with chronic kidney, lungs, Gastrointestinal tract, liver, or cardiovascular diseases) * Pregnant or breastfeeding women. * Allergy to any of the study medications and taking medications that could significantly interact with amantadine (tramadol, atropine, antipsychotic medications) * diabetes mellitus, thyroid disease any endocrine disease * Suspected difficult intubation or intubation time more than 30 second.

Design outcomes

Primary

MeasureTime frameDescription
effect of oral amantadine versus gabapentin premedication on laryngoscopy and tracheal intubation on β-endorphins.baseline blood sample taken before drug administration and after 15 minutes after intubation and before skin incisionanalysis of change of β-endorphins in blood sample

Secondary

MeasureTime frameDescription
effect of oral amantadine versus gabapentin premedication on the Mean arterial blood pressure due to laryngoscopy and tracheal intubationbaselineMAP before drug administration and after 15 minutes after intubation and before skin incisionchange of Mean arterial blood pressure
effect of oral amantadine versus gabapentin premedication on the heart rate due to laryngoscopy and tracheal intubationbaseline heart rate before drug administration and after 15 minutes after intubation and before skin incisionchange of heart rate

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026